Revenue | ₹74.57Cr |
Net Profits | ₹8.64Cr |
Net Profit Margins | 11.59% |
Balaxi Pharmaceuticals Ltd’s revenue jumped 26.09% since last year same period to ₹74.57Cr in the Q4 2024-2025. On a quarterly growth basis, Balaxi Pharmaceuticals Ltd has generated -3.44% fall in its revenue since last 3-months.
Balaxi Pharmaceuticals Ltd’s net profit fell -20.95% since last year same period to ₹8.64Cr in the Q4 2024-2025. On a quarterly growth basis, Balaxi Pharmaceuticals Ltd has generated 61.19% jump in its net profits since last 3-months.
Balaxi Pharmaceuticals Ltd’s net profit margin fell -37.31% since last year same period to 11.59% in the Q4 2024-2025. On a quarterly growth basis, Balaxi Pharmaceuticals Ltd has generated 66.94% jumped in its net profit margins since last 3-months.
The revenue for Balaxi Pharmaceuticals Ltd in the Q4 results 2024 was ₹74.57Cr.
The net profit for Balaxi Pharmaceuticals Ltd in the Q4 results 2024 was ₹8.64Cr.
The net profit margin for Balaxi Pharmaceuticals Ltd in the Q4 results 2024 was 11.59%.
The revenue for Balaxi Pharmaceuticals Ltd in the Q4 results 2023 was ₹59.14Cr.
The net profit for Balaxi Pharmaceuticals Ltd in the Q4 results 2023 was ₹10.93Cr.
The net profit margin for Balaxi Pharmaceuticals Ltd in the Q4 results 2023 was 18.48%.